Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PROCEPT BioRobotics (PRCT)
NASDAQ:PRCT
PRCT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$45.20 - $103.81
Previous CloseN/A
Volume113.34K
Average Volume (3M)871.07K
Market Cap
$3.56B
Enterprise Value$4.05B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Feb 25, 2025EPS Estimate
-0.34Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.95
Shares Outstanding54,394,722
10 Day Avg. Volume745,393
30 Day Avg. Volume871,072
Standard Deviation0.16
R-Squared0.10
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)17.55
Price to Cash Flow (P/CF)-46.60
P/FCF Ratio0.00
Enterprise Value/Market Cap1.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit57.02
Enterprise Value/Ebitda-44.70
Forecast
1Y Price Target
$106.33Price Target Upside62.61% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
PROCEPT BioRobotics News
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceThe 3Q results beat expectations, with solid US metrics across the board.
Product LaunchFDA clearance of HYDROS indicates progress in their product launch.
Sales ProjectionsManagement's public commentary suggests sell-side estimates for next year may be conservative, hinting at potential higher sales.
Bears Say
Investor PushbackThe main pushback from investors is about valuation, as PRCT is trading at a relatively high multiple to future revenue.
Rep ProductivityThere is a concern that continued rep productivity expansion to higher levels, which has not been seen over the past few years, is required.
Valuation ConcernsPRCT trades at a significant premium compared to its high-growth peers, raising concerns about high expectations given the current valuation.
---
Ownership Overview
9.87% Insiders
36.83% Mutual Funds
22.81% Other Institutional Investors
14.13% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
PRCT FAQ
What was PROCEPT BioRobotics’s price range in the past 12 months?
PROCEPT BioRobotics lowest stock price was $45.20 and its highest was $103.81 in the past 12 months.
What is PROCEPT BioRobotics’s market cap?
PROCEPT BioRobotics’s market cap is $3.56B.
When is PROCEPT BioRobotics’s upcoming earnings report date?
PROCEPT BioRobotics’s upcoming earnings report date is Feb 25, 2025 which is in 3 days.
How were PROCEPT BioRobotics’s earnings last quarter?
PROCEPT BioRobotics released its earnings results on Oct 28, 2024. The company reported -$0.4 earnings per share for the quarter, beating the consensus estimate of -$0.489 by $0.089.
Is PROCEPT BioRobotics overvalued?
According to Wall Street analysts PROCEPT BioRobotics’s price is currently Undervalued.
Does PROCEPT BioRobotics pay dividends?
PROCEPT BioRobotics does not currently pay dividends.
What is PROCEPT BioRobotics’s EPS estimate?
PROCEPT BioRobotics’s EPS estimate is -0.34.
How many shares outstanding does PROCEPT BioRobotics have?
PROCEPT BioRobotics has 54,394,722 shares outstanding.
What happened to PROCEPT BioRobotics’s price movement after its last earnings report?
PROCEPT BioRobotics reported an EPS of -$0.4 in its last earnings report, beating expectations of -$0.489. Following the earnings report the stock price went up 32.325%.
Which hedge fund is a major shareholder of PROCEPT BioRobotics?
Currently, no hedge funds are holding shares in PRCT
---
PROCEPT BioRobotics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$106.33 (62.61% Upside)
$106.33 (62.61% Upside)
Blogger Sentiment
Bullish
PRCT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 16.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $26.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.2%
Last 30 Days ▼ 4.5%
Last 30 Days ▼ 4.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
33.50%
12-Months-Change
Fundamentals
Return on Equity
-37.02%
Trailing 12-Months
Asset Growth
-11.16%
Trailing 12-Months
Company Description
PROCEPT BioRobotics
PROCEPT BioRobotics Corp is a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology.
---
PRCT Company Deck
---
PRCT Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted significant revenue growth, a successful new product launch, and high gross margins, indicating strong business momentum. However, operational challenges due to sales team training and macroeconomic factors like saline shortages and weather events have posed some challenges. The sentiment is positive, with a focus on continued growth and expansion opportunities.Read More>---
PRCT Stock 12 Month Forecast
Average Price Target
$106.33
▲(62.61% Upside)
Technical Analysis
Intuitive Surgical
―
Stereotaxis
―
Zimmer Biomet Holdings
―
Globus Medical
―
TransMedics Group
―
Best Analysts Covering PRCT
1 Year
1 Year Success Rate
12/15 ratings generated profit
1 Year Average Return
+39.75%
initiated a buy rating 3 months ago
Copying Nathan Treybeck's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +39.75% per trade.
---